Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
367
datasets available to search
ShareScore release 0.9.0
Dataset results
367 results for “Ibrutinib”
A Study of TAK-659 in Combination With Bendamustine (+/-Rituximab), Gemcitabine, Lenalidomide, or Ibrutinib for the Treatment of Participants With Advanced Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT02954406. IPD Sharing: YES. Countries: 2. Publications: 0.
A Study to Evaluate the Effects of Ibrutinib on Cardiac Repolarization in Healthy Participants
ClinicalTrials.gov study NCT02271438. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Observational Study of Lenalidomide in Subjects With Mantle Cell Lymphoma Who Failed Ibrutinib Treatment
ClinicalTrials.gov study NCT02341781. IPD Sharing: Not stated. Countries: 4. Publications: 1.
A Study Combining Ibrutinib With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With CD20-Positive B-Cell Non Hodgkin Lymphoma
ClinicalTrials.gov study NCT01569750. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Ibrutinib as an Immune Modulating Agent for Patients With Asymptomatic, High-risk CLL/SLL Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
ClinicalTrials.gov study NCT02518555. IPD Sharing: NO. Countries: 1. Publications: 1.
Is Ibrutinib-related Atrial Fibrillation Dose Dependent
ClinicalTrials.gov study NCT06224452. IPD Sharing: NO. Countries: 1. Publications: 1.
Study of Ibrutinib in Relapsed and Refractory T-cell Lymphoma
ClinicalTrials.gov study NCT02309580. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Copanlisib and Ibrutinib in Mantle Cell Lymphoma
ClinicalTrials.gov study NCT03877055. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study of PCI-32765 (Ibrutinib) in Patients With Refractory Follicular Lymphoma
ClinicalTrials.gov study NCT01779791. IPD Sharing: Not stated. Countries: 9. Publications: 2.
MALIBU Trial - Combination of Ibrutinib and Rituximab in Untreated Marginal Zone Lymphomas
ClinicalTrials.gov study NCT03697512. IPD Sharing: Not stated. Countries: 5. Publications: 0.
Ruxolitinib Combined With Ibrutinib in Chronic Lymphocytic Leukemia Patients
ClinicalTrials.gov study NCT02912754. IPD Sharing: YES. Countries: 1. Publications: 5.
A Prospective, Multicenter, Phase-II Trial of Ibrutinib Plus Venetoclax in Patients With Creatinine Clearance >= 30 ml/Min Who Have Relapsed or Refractory Chronic Lymphocytic Leukemia (RR-CLL) With or
ClinicalTrials.gov study NCT03226301. IPD Sharing: NO. Countries: 6. Publications: 3.
Pembrolizumab and Ibrutinib in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery
ClinicalTrials.gov study NCT03021460. IPD Sharing: Not stated. Countries: 1. Publications: 1.
The Safety and Efficacy of Ibrutinib in Refractory/Relapsed Autoimmune Hemolytic Anemia
ClinicalTrials.gov study NCT04398459. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study of Itacitinib (INCB039110) in Combination With Ibrutinib in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT02760485. IPD Sharing: YES. Countries: 1. Publications: 0.
Association Between Side Effects Occurrence and Concentrations of Ibrutinib and Idelalisib
ClinicalTrials.gov study NCT02824159. IPD Sharing: UNDECIDED. Countries: 1. Publications: 2.
Bruton's Tyrosine Kinase Inhibitor Ibrutinib as Maintenance Treatment in Elderly Patients With Primary CNS Lymphoma
ClinicalTrials.gov study NCT02623010. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety of Low-dose Ibrutinib and Itraconazole in Chronic Graft Versus Host Disease
ClinicalTrials.gov study NCT05348096. IPD Sharing: NO. Countries: 1. Publications: 3.
Ibrutinib Monotherapy Versus Fixed-duration Venetoclax Plus Obinutuzumab Versus Fixed-duration Ibrutinib Plus Venetoclax in Patients with Previously Untreated Chronic Lymphocytic Leukaemia (CLL)
ClinicalTrials.gov study NCT04608318. IPD Sharing: NO. Countries: 13. Publications: 1.
Rituximab, Lenalidomide, and Ibrutinib in Treating Patients With Previously Untreated Stage II-IV Follicular Lymphoma
ClinicalTrials.gov study NCT01829568. IPD Sharing: Not stated. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.